Immunoaffinity chromatographic isolation of a high molecular weight seroreactive protein from Mycobacterium leprae cell sonicate.

The purpose of this study was to isolate Mycobacterium leprae antigen(s) by immunoaffinity chromatography using immunoglobulins from leprosy patients and from rabbit anti-M. leprae hyperimmune serum coupled to CNBr-Sepharose 4B. A high molecular weight (M(r)) M. leprae protein (MLP) with a subunit M(r) of 22,000 was isolated. MLP was recognized by monoclonal antibody MMPII1G4 which is known to react with MMPII, a 22 kDa protein of M. leprae. The N-terminal sequence of the 22 kDa subunit (Met-gln-gly-asp-pro-asp-val-leu-arg-leu-leu-asn-glu-gln-leu-thr) was identical to MMPII and to antigen D (bacterioferritin) of M. paratuberculosis. It showed 44% homology with N-terminal end of E. coli bacterioferritin. In ELISA, MLP showed 100% and 60% positivity with leprosy and TB sera respectively as compared to normal healthy sera. The role of bacterioferritin in M. leprae and the importance of MLP as an immunogen has been discussed.

[1]  D. Smith,et al.  Purification, characterization, gene sequence, and significance of a bacterioferritin from Mycobacterium leprae , 1994, The Journal of experimental medicine.

[2]  R. G. Deshpande,et al.  Immunological evaluation of a 12-kilodalton protein of Mycobacterium tuberculosis by enzyme-linked immunosorbent assay. , 1993, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[3]  R. G. Deshpande,et al.  Enzyme linked immunosorbent assay of a 12-kDa protein of Mycobacterium leprae with sera from leprosy patients. , 1992, International journal of leprosy and other mycobacterial diseases.

[4]  J. Bennedsen,et al.  Results of the third immunology of leprosy/immunology of tuberculosis antimycobacterial monoclonal antibody workshop , 1992, Infection and immunity.

[5]  R. G. Deshpande,et al.  Sero-immunoreactivity of cloned protein antigens of Mycobacterium leprae. , 1992, International journal of leprosy and other mycobacterial diseases.

[6]  M. Deo,et al.  Major proteins of mycobacterial strain ICRC and Mycobacterium leprae, identified by antibodies in sera from leprosy patients and their contacts , 1992, Journal of clinical microbiology.

[7]  R. H. Robertson,et al.  Mycobacterium paratuberculosis antigen D: characterization and evidence that it is a bacterioferritin , 1991, Journal of clinical microbiology.

[8]  D. Watson,et al.  Chromatographic purification and characterization of antigens A and D from Mycobacterium paratuberculosis and their use in enzyme-linked immunosorbent assays for diagnosis of paratuberculosis in sheep , 1991, Journal of clinical microbiology.

[9]  P. Brennan,et al.  The major native proteins of the leprosy bacillus. , 1990, The Journal of biological chemistry.

[10]  J. Lamb,et al.  Molecular study of the T cell repertoire in family contacts and patients with leprosy. , 1989, Journal of immunology.

[11]  T. Ottenhoff,et al.  T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components , 1989, European journal of immunology.

[12]  R. Young,et al.  Stress proteins are immune targets in leprosy and tuberculosis. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[13]  P. Converse,et al.  Cellular, Humoral, and Gamma Interferon Responses to Mycobacterium leprae and BCG Antigens in Healthy Individuals Exposed to Leprosy , 1988, Scandinavian journal of immunology.

[14]  A. Basten,et al.  Antigens of Mycobacterium leprae identified by immunoprecipitation with sera from leprosy and tuberculosis patients. , 1988, Clinical and Experimental Immunology.

[15]  Ronald W. Davis,et al.  Genes for the major protein antigens of the leprosy parasite Mycobacterium leprae , 1985, Nature.

[16]  P. Klatser,et al.  Immunochemical characterization of Mycobacterium leprae antigens by the SDS-polyacrylamide gel electrophoresis immunoperoxidase technique (SGIP) using patients' sera. , 1984, Clinical and experimental immunology.

[17]  S. Halstead.  Selective primary health care: strategies for control of disease in the developing world. XI. Dengue. , 1984, Reviews of infectious diseases.

[18]  T. Godal,et al.  Selective primary health care: strategies for control of disease in the developing world. V. Leprosy. , 1983, Reviews of infectious diseases.

[19]  Ridley Ds,et al.  Classification of leprosy according to immunity. A five-group system. , 1966 .